Circulating Tumor Cell (CTC) Diagnostics Market - Global Outlook and Forecast 2022-2028

Circulating Tumor Cell (CTC) Diagnostics Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Circulating Tumor Cell (CTC) Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Circulating Tumor Cell (CTC) Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Circulating Tumor Cell (CTC) Diagnostics Overall Market Size
2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size: 2021 VS 2028
2.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Circulating Tumor Cell (CTC) Diagnostics Players in Global Market
3.2 Top Global Circulating Tumor Cell (CTC) Diagnostics Companies Ranked by Revenue
3.3 Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Circulating Tumor Cell (CTC) Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Circulating Tumor Cell (CTC) Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Circulating Tumor Cell (CTC) Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Circulating Tumor Cell (CTC) Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Circulating Tumor Cell (CTC) Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Circulating Tumor Cell (CTC) Diagnostics Market Size Markets, 2021 & 2028
4.1.2 CTC Enrichment
4.1.3 CTC Detection
4.2 By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Circulating Tumor Cell (CTC) Diagnostics Market Size, 2021 & 2028
5.1.2 Hospitals and clinics
5.1.3 Pharmaceuticals and biotechnology companies
5.1.4 Academic research institutes
5.1.5 CROs
5.2 By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Circulating Tumor Cell (CTC) Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Circulating Tumor Cell (CTC) Diagnostics Revenue, 2017-2028
6.3.2 US Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.3.3 Canada Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.3.4 Mexico Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Circulating Tumor Cell (CTC) Diagnostics Revenue, 2017-2028
6.4.2 Germany Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.4.3 France Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.4.4 U.K. Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.4.5 Italy Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.4.6 Russia Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.4.8 Benelux Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Circulating Tumor Cell (CTC) Diagnostics Revenue, 2017-2028
6.5.2 China Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.5.3 Japan Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.5.4 South Korea Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.5.6 India Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Circulating Tumor Cell (CTC) Diagnostics Revenue, 2017-2028
6.6.2 Brazil Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.6.3 Argentina Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Revenue, 2017-2028
6.7.2 Turkey Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.7.3 Israel Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
6.7.5 UAE Circulating Tumor Cell (CTC) Diagnostics Market Size, 2017-2028
7 Players Profiles
7.1 ApoCell, Inc.(US)
7.1.1 ApoCell, Inc.(US) Corporate Summary
7.1.2 ApoCell, Inc.(US) Business Overview
7.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.1.4 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.1.5 ApoCell, Inc.(US) Key News
7.2 Biocep Ltd. (Israel)
7.2.1 Biocep Ltd. (Israel) Corporate Summary
7.2.2 Biocep Ltd. (Israel) Business Overview
7.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.2.4 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Biocep Ltd. (Israel) Key News
7.3 Biocept, Inc.(US)
7.3.1 Biocept, Inc.(US) Corporate Summary
7.3.2 Biocept, Inc.(US) Business Overview
7.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.3.4 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Biocept, Inc.(US) Key News
7.4 Biofluidica MicrotechnologiesLLc(US)
7.4.1 Biofluidica MicrotechnologiesLLc(US) Corporate Summary
7.4.2 Biofluidica MicrotechnologiesLLc(US) Business Overview
7.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.4.4 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Biofluidica MicrotechnologiesLLc(US) Key News
7.5 Celltraffix Inc.(US)
7.5.1 Celltraffix Inc.(US) Corporate Summary
7.5.2 Celltraffix Inc.(US) Business Overview
7.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.5.4 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Celltraffix Inc.(US) Key News
7.6 ClearbridgeBiomedics(Singapore)
7.6.1 ClearbridgeBiomedics(Singapore) Corporate Summary
7.6.2 ClearbridgeBiomedics(Singapore) Business Overview
7.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.6.4 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.6.5 ClearbridgeBiomedics(Singapore) Key News
7.7 Creatv Microtech, Inc.(US)
7.7.1 Creatv Microtech, Inc.(US) Corporate Summary
7.7.2 Creatv Microtech, Inc.(US) Business Overview
7.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.7.4 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Creatv Microtech, Inc.(US) Key News
7.8 CynvenioBiosystems, Inc.(US)
7.8.1 CynvenioBiosystems, Inc.(US) Corporate Summary
7.8.2 CynvenioBiosystems, Inc.(US) Business Overview
7.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.8.4 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.8.5 CynvenioBiosystems, Inc.(US) Key News
7.9 EpicBiosciencesInc.(US)
7.9.1 EpicBiosciencesInc.(US) Corporate Summary
7.9.2 EpicBiosciencesInc.(US) Business Overview
7.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.9.4 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.9.5 EpicBiosciencesInc.(US) Key News
7.10 FluxionBiosciences, Inc.(US)
7.10.1 FluxionBiosciences, Inc.(US) Corporate Summary
7.10.2 FluxionBiosciences, Inc.(US) Business Overview
7.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.10.4 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.10.5 FluxionBiosciences, Inc.(US) Key News
7.11 Ikonisys, Inc.(US)
7.11.1 Ikonisys, Inc.(US) Corporate Summary
7.11.2 Ikonisys, Inc.(US) Business Overview
7.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.11.4 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.11.5 Ikonisys, Inc.(US) Key News
7.12 IVDiagnostics, Inc.(US)
7.12.1 IVDiagnostics, Inc.(US) Corporate Summary
7.12.2 IVDiagnostics, Inc.(US) Business Overview
7.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.12.4 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.12.5 IVDiagnostics, Inc.(US) Key News
7.13 JanssenDiagnosticsLLc(US)
7.13.1 JanssenDiagnosticsLLc(US) Corporate Summary
7.13.2 JanssenDiagnosticsLLc(US) Business Overview
7.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.13.4 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.13.5 JanssenDiagnosticsLLc(US) Key News
7.14 QIAGEnHannoverGmbH (Germany)
7.14.1 QIAGEnHannoverGmbH (Germany) Corporate Summary
7.14.2 QIAGEnHannoverGmbH (Germany) Business Overview
7.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.14.4 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.14.5 QIAGEnHannoverGmbH (Germany) Key News
7.15 RARECELLsSAs(Italy)
7.15.1 RARECELLsSAs(Italy) Corporate Summary
7.15.2 RARECELLsSAs(Italy) Business Overview
7.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.15.4 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.15.5 RARECELLsSAs(Italy) Key News
7.16 ScreenCell(France)
7.16.1 ScreenCell(France) Corporate Summary
7.16.2 ScreenCell(France) Business Overview
7.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.16.4 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.16.5 ScreenCell(France) Key News
7.17 STEMCELlTechnologies, Inc.(Canada)
7.17.1 STEMCELlTechnologies, Inc.(Canada) Corporate Summary
7.17.2 STEMCELlTechnologies, Inc.(Canada) Business Overview
7.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Major Product Offerings
7.17.4 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Revenue in Global Market (2017-2022)
7.17.5 STEMCELlTechnologies, Inc.(Canada) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Circulating Tumor Cell (CTC) Diagnostics Market Opportunities & Trends in Global Market
Table 2. Circulating Tumor Cell (CTC) Diagnostics Market Drivers in Global Market
Table 3. Circulating Tumor Cell (CTC) Diagnostics Market Restraints in Global Market
Table 4. Key Players of Circulating Tumor Cell (CTC) Diagnostics in Global Market
Table 5. Top Circulating Tumor Cell (CTC) Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Circulating Tumor Cell (CTC) Diagnostics Product Type
Table 9. List of Global Tier 1 Circulating Tumor Cell (CTC) Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Circulating Tumor Cell (CTC) Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Circulating Tumor Cell (CTC) Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. ApoCell, Inc.(US) Corporate Summary
Table 31. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 32. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Biocep Ltd. (Israel) Corporate Summary
Table 34. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 35. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Biocept, Inc.(US) Corporate Summary
Table 37. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 38. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Biofluidica MicrotechnologiesLLc(US) Corporate Summary
Table 40. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 41. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Celltraffix Inc.(US) Corporate Summary
Table 43. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 44. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. ClearbridgeBiomedics(Singapore) Corporate Summary
Table 46. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 47. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Creatv Microtech, Inc.(US) Corporate Summary
Table 49. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 50. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. CynvenioBiosystems, Inc.(US) Corporate Summary
Table 52. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 53. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. EpicBiosciencesInc.(US) Corporate Summary
Table 55. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 56. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. FluxionBiosciences, Inc.(US) Corporate Summary
Table 58. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 59. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. Ikonisys, Inc.(US) Corporate Summary
Table 61. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 62. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. IVDiagnostics, Inc.(US) Corporate Summary
Table 64. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 65. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 66. JanssenDiagnosticsLLc(US) Corporate Summary
Table 67. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 68. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 69. QIAGEnHannoverGmbH (Germany) Corporate Summary
Table 70. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 71. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 72. RARECELLsSAs(Italy) Corporate Summary
Table 73. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 74. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 75. ScreenCell(France) Corporate Summary
Table 76. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 77. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 78. STEMCELlTechnologies, Inc.(Canada) Corporate Summary
Table 79. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Product Offerings
Table 80. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Circulating Tumor Cell (CTC) Diagnostics Segment by Type in 2021
Figure 2. Circulating Tumor Cell (CTC) Diagnostics Segment by Application in 2021
Figure 3. Global Circulating Tumor Cell (CTC) Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Circulating Tumor Cell (CTC) Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Circulating Tumor Cell (CTC) Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2021
Figure 8. By Type - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Circulating Tumor Cell (CTC) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Prostate Cancer Diagnostics market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Diagnostics is forecast to a readjusted size of US$ 22650 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global Prostate Cancer Diagnostics market. Prostate Cancer Diagnostics are expected to show stable growth in th......

Global Checkpoint Inhibitors for Treating Cancer Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83

According to our LPI (LP Information) latest study, the global Checkpoint Inhibitors for Treating Cancer market size was valued at US$ 12220 million in 2023. With growing demand in downstream market, the Checkpoint Inhibitors for Treating Cancer is forecast to a readjusted size of US$ 63530 million by 2030 with a CAGR of 26.6% during review period. The research report highlights the growth potential of the global Checkpoint Inhibitors for Treating Cancer market. Checkpoint Inhibitors for......

Global PSA Test Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111

According to our LPI (LP Information) latest study, the global PSA Test market size was valued at US$ 499.9 million in 2023. With growing demand in downstream market, the PSA Test is forecast to a readjusted size of US$ 861.8 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global PSA Test market. PSA Test are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global HPV Testing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87

According to our LPI (LP Information) latest study, the global HPV Testing market size was valued at US$ 784.6 million in 2023. With growing demand in downstream market, the HPV Testing is forecast to a readjusted size of US$ 1398.7 million by 2030 with a CAGR of 8.6% during review period. The research report highlights the growth potential of the global HPV Testing market. HPV Testing are expected to show stable growth in the future market. However, product differentiation, reducing cos......

Global Prostate Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 102

According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics market size was valued at USD 13820 million in 2023 and is forecast to a readjusted size of USD 22870 million by 2030 with a CAGR of 7.5% during review period. The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be ......

Global Pap Tests and HPV Tests Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 130

The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......

Global Pap Tests and HPV Tests Professional Survey Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 106

The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......

Global Checkpoint Inhibitors For Treating Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Checkpoint Inhibitors For Treating Cancer market: According to our latest research, the global Checkpoint Inhibitors For Treating Cancer market looks promising in the next 5 years. As of 2022, the global Checkpoint Inhibitors For Treating Cancer market was estimated at USD 18595.4 million, and it's anticipated to reach USD 42557.61 million in 2028, with a CAGR of 14.8% during the forecast years. Checkpoint inhibitor is a type of drug used in immunoth......

Global Solid Tumor Testing Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 100

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs